Quinfamide
| |
Clinical data | |
---|---|
Routes of administration | Oral |
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ECHA InfoCard |
100.057.690 |
Chemical and physical data | |
Formula | C16H13Cl2NO4 |
Molar mass | 354.18472 g/mol |
3D model (JSmol) | |
| |
| |
|
Quinfamide, is a drug that has anti-parasitic properties.[1]
Synthesis
Quinfamide is one of a relatively small family of antiamoebic compounds containing a dichloroacetamide function.
The synthesis begins by amidation of 6-hydroxytetrahydroquinoline with dichloroacetyl chloride. The sequence is completed by acylation with 2-furoyl chloride.
References
- ↑ Davila-Gutierrez, CE.; Vasquez, C.; Trujillo-Hernandez, B.; Huerta, M. (Mar 2002). "Nitazoxanide compared with quinfamide and mebendazole in the treatment of helminthic infections and intestinal protozoa in children". Am J Trop Med Hyg. 66 (3): 251–4. PMID 12139216.
- ↑ D. M. Bailey, U.S. Patent 3,997,542 (1976 to Sterling).
- ↑ Bailey, Denis M.; Mount, Eldridge M.; Siggins, James; Carlson, John A.; Yarinsky, Allen; Slighter, Ralph G. (1979). "1-(Dichloroacetyl)-1,2,3,4-tetrahydro-6-quinolinol esters. New potent antiamebic agents". Journal of Medicinal Chemistry. 22 (5): 599. doi:10.1021/jm00191a031. PMID 458814.
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.